Musings Of Monkeesfan
A blog on varied subjects by Michael Daly.
Wednesday, January 20, 2016
House Fraudulence About Drug CEO Martin Shkreli
Martin Shkreli was CEO of Turing Pharmaceuticals and in 2015 he bought the rights to a drug whose price he raised to $750.00 a pop. A lot of social media sanctimony followed, and he's been supoenaed by the House of Representatives. The problem, though, is the usual one -
Shkreli is not the problem, government meddling created his so-called "price-gouging."
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)